Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

435.25 +2.19 (+0.50%)

Streaming Delayed Price Updated: 9:36 AM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

72 73 Next >

3 Growth Stocks to Buy That Could Be Massive Long-Term Winners ↗

January 14, 2024

These stocks appear to have what it takes to keep up their winning ways.

Via The Motley Fool

3 Unstoppable Stocks to Buy in 2024 ↗

January 13, 2024

These stocks appear to be on a clear path to continued growth.

Via The Motley Fool

Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week ↗

January 13, 2024

These companies could stand out thanks to game-changing technology.

Via The Motley Fool

Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' ↗

January 12, 2024

On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. (NYSE: UBER) shares hit an all-time high on Thursda

Via Benzinga

3 Stocks to Buy in the Booming Field of Gene Editing ↗

January 11, 2024

As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains.

Via InvestorPlace

Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals ↗

January 11, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 16 Analysts ↗

January 09, 2024

Via Benzinga

A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings ↗

January 09, 2024

Via Benzinga

Should Quality-Oriented Investors Explore VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX)? ↗

January 11, 2024

Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX).

Via Chartmill

10 Health Care Stocks With Whale Alerts In Today's Session ↗

January 10, 2024

Via Benzinga

2 Red Flags for Bluebird Bio Stock ↗

January 10, 2024

The biotech's struggles may continue.

Via The Motley Fool

These 3 Stocks Have Beaten the S&P Average Return for Years and Are Likely to Continue That Trend ↗

January 10, 2024

These winners seem likely to keep up their winning ways.

Via The Motley Fool

Topics Stocks

Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia

January 09, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

$1000 Invested In This Stock 15 Years Ago Would Be Worth $14,000 Today ↗

January 08, 2024

Via Benzinga

Is Vertex Pharmaceuticals Stock a Buy Now? ↗

January 06, 2024

The biotech's prospects keep improving.

Via The Motley Fool

2 low-priced gene therapy stocks to speculate on

January 08, 2024

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic diffe

Via MarketBeat

5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday ↗

January 08, 2024

The rebound by biopharma stocks in 2023 and the pickup in M&A news flow makes the 2024 JPMorgan Healthcare conference even more interesting.

Via Benzinga

The Ultimate Growth Stock to Buy With $1,000 Right Now ↗

January 08, 2024

The stock, trading for about $60, has plenty of room to run.

Via The Motley Fool

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

January 07, 2024

From Vertex Pharmaceuticals Incorporated

Via Business Wire

5 Top Stocks to Buy in January ↗

January 07, 2024

Start the year off right by investing in these quality businesses.

Via The Motley Fool

Investing Trends to Follow in 2024 ↗

January 06, 2024

We've also got Motley Fool co-founder Tom Gardner sharing an investing lesson from last year and a stock for this one.

Via The Motley Fool

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Via Investor's Business Daily

2 Biotech Stocks With Huge Catalysts in 2024 ↗

January 05, 2024

Important clinical-trial readouts on the way could send these stocks soaring in early 2024.

Via The Motley Fool

Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors ↗

January 04, 2024

Gen Z stocks include companies the generation prefers to invest in while capturing the emerging economic force they represent.

Via InvestorPlace

Will the Biotech sector sustain its momentum in 2024?

January 04, 2024

The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.

Via MarketBeat

Topics ETFs

The Best Stocks to Invest $1,000 in Right Now ↗

January 04, 2024

It's not too late to get in on these market beaters.

Via The Motley Fool

Here's Why 2024 Could Be a Big Year for CRISPR Therapeutics ↗

January 04, 2024

CRISPR Therapeutics' shares climbed considerably last year -- but more gains could be just ahead.

Via The Motley Fool

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition ↗

January 03, 2024

Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.

Via InvestorPlace

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Climbs to New 52-Week High

January 03, 2024

Via Investor Brand Network

January Has Been 1 of the Worst Months for the S&P 500 Over the Last 20 Years. Here Are 3 Stocks to Buy Anyway. ↗

January 03, 2024

These stocks are smart picks to buy now, regardless of whether the S&P 500 stocks start off 2024 poorly.

Via The Motley Fool

Topics Stocks

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

72 73 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.